CDSCO approves ‘Palivizumab’, a long-awaited preventive therapy for Respiratory Syncytial Virus September 30, 2023 AstraZeneca Pharma India on Saturday announced the marketing approval from Central Drugs Standard Control Organisation (CDSCO) to import and market ‘Palivizumab’ injection 100 mg/ml (r-DNA origin) (50mg/0.5mL &... Trending 29-year-old woman undergoes breast reconstruction for childhood burn deformity Why India needs uniform strategy for equitable access to Cancer treatment, experts explain 22-year-old woman undergoes for decade long facial tumour through Scarless Surgery Latest 29-year-old woman undergoes breast reconstruction for childhood burn deformity Zydus signs MoU with Apollo Hospitals for multi-cancer early detection test Why India needs uniform strategy for equitable access to Cancer treatment, experts explain Centre bans sale of Cough syrups without valid prescription
